ChaAE, CohenRA. National Health Statistics Reports, Number 169, February 11, 2022. 2022;(169):15.
2.
ChildersCP, ChildersKK, Maggard-GibbonsM, et al.National estimates of genetic testing in women with a history of breast or ovarian cancer. J Clin Oncol, 2017; 35(34):3800-3806; doi: 10.1200/JCO.2017.73.6314
3.
CiuroJ, BeyerA, FritzlerJ, et al.Health care disparities and demand for expanding hereditary breast cancer screening guidelines in African Americans. Clin Breast Cancer, 2021; 21(3):e220-e227; doi: 10.1016/j.clbc.2020.08.010
4.
CohenSA, BradburyA, HendersonV, et al.Genetic Counseling and Testing in a Community Setting: Quality, access, and efficiency. Am Soc Clin Oncol Educ Book, 2019;(39):e34-e44; doi: 10.1200/EDBK_238937
5.
CragunD, WeidnerA, LewisC, et al.Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors. Cancer, 2017; 123(13):2497-2505; doi: 10.1002/cncr.30621
6.
FoglemanAJ, ZahndWE, LipkaAE, et al.Knowledge, attitudes, and perceived barriers towards genetic testing across Three Rural Illinois Communities. J Community Genet, 2019; 10(3):417-423; doi: 10.1007/s12687-019-00407-w
7.
HannKEJ, FreemanM, FraserL, et al.Awareness, Knowledge, Perceptions, and Attitudes Towards Genetic Testing for Cancer Risk Among Ethnic Minority Groups: A Systematic Review—PMC; 2017. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445407/ [Last accessed: January 19, 2023].
SandlerS, AlfinoL, SaleemM. The importance of preventative medicine in conjunction with modern day genetic studies. Genes Dis, 2018; 5(2):107-111; doi: 10.1016/j.gendis.2018.04.002
